Summary
The present analysis aims to investigate the prevalence of thyroid nodules in type 2 diabetes mellitus (T2DM) population. We searched PubMed, EMBASE, and Web of Science from inception to the March 1, 2018. The studies were selected to estimate the prevalence of thyroid nodules in T2DM subjects and to compare the prevalence of thyroid nodules in different glucose tolerance status. The random effects model was used, and the outcome was presented as a pooled prevalence proportion with 95% confidence interval (95% CI) or a summary odds ratio (OR) with 95% CI. In the end, 9 studies met the inclusion criteria and were included in the analysis. The pooled prevalence of thyroid nodules was 60% (95% CI: 0.52, 0.68) for T2DM 2 diabetes patients, 50% (95% CI: 0.48, 0.51) for pre-diabetes, and 43% (95% CI: 0.34, 0.52) for normal glucose tolerance population. Compared with patients without diabetes, diabetes subjects are more likely to develop thyroid nodules, adjusted OR for thyroid nodule was 1.78 (95% CI: 1.25, 2.55). Insulin resistance might be involved in thyroid nodule development.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res, 2011,2011:439463
Peppa M, Koliaki C, Nikolopoulos P, et al. Skeletal muscle insulin resistance in endocrine disease. J Biomed Biotechnol, 2010,2010:527850
Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf), 2011,75(1):1–9
Han C, He X, Xia X, et al. Subclinical Hypothyroidism and Type 2 Diabetes: A Systematic Review and Meta-Analysis. PLoS One, 2015,10(8):e0135233
Gierach M, Gierach J, Junik R. Insulin resistance and thyroid disorders. Endokrynol Pol, 2014,65(1):70–76
Han C, Xia X, Liu A, et al. Circulating Betatrophin Is Increased in Patients with Overt and Subclinical Hypothyroidism. Biomed Res Int, 2016,2016:5090852
Agbaht K, Erdogan MF, Emral R, et al. Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism. Endocrine, 2014,45(1):106–113
Miyauchi S, Matsuura B, Ueda T, et al. Interleukin-18 induces insulin resistance in the hyperthyroid state. Endocr J, 2013,60(4):449–455
Wang C. The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases. J Diabetes Res, 2013,2013:390534
Kadiyala R, Peter R, Okosieme OE. Thyroid dysfunction in patients with diabetes: clinical implications and screening strategies. Int J Clin Pract, 2010,64(8):1130–1139
Rai S, Kumar JA, KP, et al. Thyroid function in type 2 diabetes mellitus and in diabetic nephropathy. J Clin Diagn Res, 2013,7(8):1583–1585
Somwaru LL, Arnold AM, Joshi N, et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab, 2009,94(4):1342–1345
Gharib H, Papini E. Thyroid nodules: clinical importance, assessment, and treatment. Endocrinol Metab Clin North Am, 2007,36(3):707–735, vi
Ayturk S, Gursoy A, Kut A, et al. Metabolic syndrome and its components are associated with increased thyroid volume and nodule prevalence in a mild-to-moderate iodine-deficient area. Eur J Endocrinol, 2009,161(4):599–605
Rezzonico J, Rezzonico M, Pusiol E, et al. Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid, 2008,18(4):461–464
Junik R, Kozinski M, Debska- Kozinska K. Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiologica, 2006,47(7):687–691
Anil C, Akkurt A, Ayturk S, et al. Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism, 2013,62(7):970–975
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. fJAMA, 2000,283(15):2008–2012
Liu Y, Liu J, Zhang T, et al. Type 2 diabetes mellitus associated with thyroid nodules: a longitudinal health check-up cohort study. J Shandong Univ (Chinese), 2015,53(8):83–86
Huang XQ, Zhang HA, Huang Q. Correlation analysis between type 2 diabetes mellitus and thyroid nodules in elderly patients. Dier Junyi Daxue Xuebao (Chinese), 2015,36(2):221–225
Ittermann T, Markus MR, Schipf S, et al. Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol, 2013,169(1):9–15
Guo H, Sun M, He W, et al. The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years. Endocrine, 2014,45(2):230–235
Tu W, Zhang G, Yu S, et al. Observations on factors that influence thyroid nodules in diabetic and non-diabetic patients in the Zhejiang province of China. Int J Clin Exp Med, 2015,8(10):19332–19338
Zheng L, Yan W, Kong Y, et al. An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women. Int J Clin Exp Med, 2015,8(7):11379–11387
Tao YH, Bi FF, Liu GL. Analysis of the prevalence rate and risk factors of thyroid nodules in Tangshan City. Occupation Health (Chinese), 2014,30(23):3415–3417
Rezzonico JN, Rezzonico M, Pusiol E, et al. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord, 2009,7(4):375–380
Godsland IF. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci (Lond), 2009,118(5):315–332
Jalving M, Gietema JA, Lefrandt JD, et al. Metformin: taking away the candy for cancer? Eur J Cancer, 2010,46(13):2369–2380
Silberschmidt D, Krawiec L, Bocanera LV, et al. Effect of the interaction of TSH and insulin on the stimulation of 2-deoxyglucose uptake in FRTL-5 cells. J Endocrinol Invest, 1999,22(7):499–502
Blancquaert S, Wang L, Paternot S, et al. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Mol Endocrinol, 2010,24(7):1453–1468
Santisteban P, Acebron A, Polycarpou-Schwarz M, et al. Insulin and insulin-like growth factor I regulate a thyroid-specific nuclear protein that binds to the thyroglobulin promoter. Mol Endocrinol, 1992,6(8):1310–1317
Rapoport B, Chazenbalk GD, Jaume JC, et al. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev, 1998,19(6):673–716
Kimura T, Van Keymeulen A, Golstein J, et al. Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocr Rev, 2001,22(5):631–656
Rapp K, Schroeder J, Klenk J, et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia, 2006,49(5):945–952
Inoue M, Iwasaki M, Otani T, et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med, 2006,166(17):1871–1877
Blanc E, Ponce C, Brodschi D, et al. Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome. Metab Syndr Relat Disord, 2015,13(5):221–226
Santos MC, Louzada RA, Souza EC, et al. Diabetes mellitus increases reactive oxygen species production in the thyroid of male rats. Endocrinology, 2013,154(3):1361–1372
Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014,103(2):137–149
Author information
Authors and Affiliations
Corresponding authors
Additional information
This project was supported by the National Natural Science Foundation of China (No. 81300642).
Conflict of Interest Statement
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Zhang, Hm., Feng, Qw., Niu, Yx. et al. Thyroid Nodules in Type 2 Diabetes Mellitus. CURR MED SCI 39, 576–581 (2019). https://doi.org/10.1007/s11596-019-2076-5
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-019-2076-5